In addition, a study found that ROS levels increased in GC cells treated with 5-FU, which induced activation of hypoxia-inducible factor-1α (HIF-1α) signaling, driving expression of HMGB1 and resulting in more tumor-associated macrophages (TAMs) being recruited into GC. The gene discussed is HIF1A; the disease is gastric cancer.